Depomed Announces Acquisition Of Zipsor® (diclofenac potassium) From Xanodyne Pharmaceuticals, Inc. – Yahoo Finance

MENLO PARK, Calif., June 21, 2012 /PRNewswire/ — Depomed, Inc. (DEPO) today announced that it has acquired all rights to Zipsor ® (diclofenac potassium) Liquid Filled Capsules from Xanodyne Pharmaceuticals, Inc.  Zipsor is a non-steroidal …

Leave a Reply

Your email address will not be published.